IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 246 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $902,295 | +435.1% | 93,697 | +490.4% | 0.00% | – |
| Q2 2023 | $168,617 | +58.8% | 15,871 | +57.3% | 0.00% | – |
| Q1 2023 | $106,160 | -34.1% | 10,091 | -22.0% | 0.00% | – |
| Q4 2022 | $161,000 | +3.9% | 12,942 | -14.3% | 0.00% | – |
| Q3 2022 | $155,000 | -9.9% | 15,103 | +0.7% | 0.00% | – |
| Q2 2022 | $172,000 | -9.0% | 14,998 | +0.1% | 0.00% | – |
| Q1 2022 | $189,000 | +11.8% | 14,985 | +3.8% | 0.00% | – |
| Q4 2021 | $169,000 | +59.4% | 14,432 | +77.2% | 0.00% | – |
| Q3 2021 | $106,000 | +278.6% | 8,143 | +267.6% | 0.00% | – |
| Q2 2021 | $28,000 | +55.6% | 2,215 | +34.7% | 0.00% | – |
| Q1 2021 | $18,000 | -35.7% | 1,645 | -30.2% | 0.00% | – |
| Q4 2020 | $28,000 | +86.7% | 2,356 | +39.4% | 0.00% | – |
| Q3 2020 | $15,000 | -44.4% | 1,690 | -34.5% | 0.00% | – |
| Q2 2020 | $27,000 | +1250.0% | 2,580 | +1729.8% | 0.00% | – |
| Q1 2020 | $2,000 | – | 141 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,855,515 | $43,661,000 | 13.90% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 772,369 | $11,810,000 | 7.13% |
| Rubric Capital Management LP | 1,275,000 | $19,495,000 | 6.70% |
| SECTOR GAMMA AS | 1,972,678 | $30,162,000 | 5.68% |
| BRIDGER MANAGEMENT, LLC | 1,879,313 | $28,735,000 | 2.00% |
| Asymmetry Capital Management, L.P. | 57,363 | $877,000 | 1.63% |
| Orbimed Advisors | 7,241,300 | $110,719,000 | 1.41% |
| Broderick Brian C | 144,476 | $2,209,000 | 0.96% |
| Granahan Investment Management | 1,408,000 | $21,528,000 | 0.74% |
| Spark Investment Management LLC | 499,200 | $7,632,000 | 0.63% |